Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 23275441)

1.

Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease.

Lin JT, Chang WC, Chen HM, Lai HL, Chen CY, Tao MH, Chern Y.

Mol Cell Biol. 2013 Mar;33(5):1073-84. doi: 10.1128/MCB.01434-12. Epub 2012 Dec 28.

2.

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.

Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, Beal MF, Brouillet E.

Hum Mol Genet. 2013 Oct 1;22(19):3869-82. doi: 10.1093/hmg/ddt242. Epub 2013 May 29.

3.

Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.

Hunter JM, Lesort M, Johnson GV.

J Neurosci Res. 2007 Jun;85(8):1774-88.

PMID:
17455294
4.

The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.

Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y.

Hum Mol Genet. 2009 Aug 15;18(16):2929-42. doi: 10.1093/hmg/ddp230. Epub 2009 May 14.

5.

Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease.

Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ, Sun CP, Tao MH, Tu PH, Chang C, Dickson DW, Chern Y.

J Cell Biol. 2011 Jul 25;194(2):209-27. doi: 10.1083/jcb.201105010. Epub 2011 Jul 18.

6.

Gastrodia elata prevents huntingtin aggregations through activation of the adenosine A₂A receptor and ubiquitin proteasome system.

Huang CL, Yang JM, Wang KC, Lee YC, Lin YL, Yang YC, Huang NK.

J Ethnopharmacol. 2011 Oct 31;138(1):162-8. doi: 10.1016/j.jep.2011.08.075. Epub 2011 Sep 8.

PMID:
21924340
7.

Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.

Roze E, Betuing S, Deyts C, Marcon E, Brami-Cherrier K, Pagès C, Humbert S, Mérienne K, Caboche J.

FASEB J. 2008 Apr;22(4):1083-93. Epub 2007 Nov 20.

8.

In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.

Thomas EA, Coppola G, Tang B, Kuhn A, Kim S, Geschwind DH, Brown TB, Luthi-Carter R, Ehrlich ME.

Hum Mol Genet. 2011 Mar 15;20(6):1049-60. doi: 10.1093/hmg/ddq548. Epub 2010 Dec 20.

9.

BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtin.

Leon R, Bhagavatula N, Ulukpo O, McCollum M, Wei J.

Eur J Neurosci. 2010 Jun;31(11):1915-25. doi: 10.1111/j.1460-9568.2010.07215.x. Epub 2010 May 24.

10.
11.

AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.

Ju TC, Chen HM, Chen YC, Chang CP, Chang C, Chern Y.

Biochim Biophys Acta. 2014 Sep;1842(9):1668-80. doi: 10.1016/j.bbadis.2014.06.012. Epub 2014 Jun 16.

PMID:
24946181
12.

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.

Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y.

Hum Mol Genet. 2013 May 1;22(9):1826-42. doi: 10.1093/hmg/ddt036. Epub 2013 Jan 30.

13.

Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.

Dai Y, Dudek NL, Li Q, Fowler SC, Muma NA.

J Neurosci. 2009 Sep 16;29(37):11550-9. doi: 10.1523/JNEUROSCI.3307-09.2009.

15.

Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.

Wang J, Wang CE, Orr A, Tydlacka S, Li SH, Li XJ.

J Cell Biol. 2008 Mar 24;180(6):1177-89. doi: 10.1083/jcb.200709080.

16.

Implication of the JNK pathway in a rat model of Huntington's disease.

Perrin V, Dufour N, Raoul C, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Déglon N.

Exp Neurol. 2009 Jan;215(1):191-200. doi: 10.1016/j.expneurol.2008.10.008. Epub 2008 Oct 28.

PMID:
19022249
17.

Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.

Jia H, Kast RJ, Steffan JS, Thomas EA.

Hum Mol Genet. 2012 Dec 15;21(24):5280-93. doi: 10.1093/hmg/dds379. Epub 2012 Sep 10.

18.

Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.

Giralt A, Saavedra A, Carretón O, Xifró X, Alberch J, Pérez-Navarro E.

Hum Mol Genet. 2011 Nov 1;20(21):4232-47. doi: 10.1093/hmg/ddr351. Epub 2011 Aug 11.

19.

Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease.

Lin YS, Cheng TH, Chang CP, Chen HM, Chern Y.

Biochim Biophys Acta. 2013 Jun;1832(6):742-53. doi: 10.1016/j.bbadis.2013.02.006. Epub 2013 Feb 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk